These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 25048725)
21. Is alpha-B crystallin an independent marker for prognosis in lung cancer? Campbell-Lloyd AJ; Mundy J; Deva R; Lampe G; Hawley C; Boyle G; Griffin R; Thompson C; Shah P Heart Lung Circ; 2013 Sep; 22(9):759-66. PubMed ID: 23582651 [TBL] [Abstract][Full Text] [Related]
22. Altered expression of 17‑β‑hydroxysteroid dehydrogenase type 2 and its prognostic significance in non‑small cell lung cancer. Drzewiecka H; Jarmołowska-Jurczyszyn D; Kluk A; Gałęcki B; Dyszkiewicz W; Jagodziński PP Int J Oncol; 2020 Jun; 56(6):1352-1372. PubMed ID: 32236582 [TBL] [Abstract][Full Text] [Related]
23. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival. Ni SS; Zhang J; Zhao WL; Dong XC; Wang JL Tumour Biol; 2013 Jun; 34(3):1813-8. PubMed ID: 23475633 [TBL] [Abstract][Full Text] [Related]
24. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas. Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856 [TBL] [Abstract][Full Text] [Related]
25. Analysis of MAT3 gene expression in NSCLC. Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548 [TBL] [Abstract][Full Text] [Related]
26. CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression. Yin X; Xia J; Sun Y; Zhang Z BMC Pulm Med; 2020 Feb; 20(1):40. PubMed ID: 32054470 [TBL] [Abstract][Full Text] [Related]
27. Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC). Tang Z; Shen Q; Xie H; Zhou X; Li J; Feng J; Liu H; Wang W; Zhang S; Ni S Oncotarget; 2016 Jul; 7(29):46253-46262. PubMed ID: 27323829 [TBL] [Abstract][Full Text] [Related]
28. Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer. Yang J; Li Y; Khoury T; Alrawi S; Goodrich DW; Tan D Ann Clin Lab Sci; 2008; 38(2):105-12. PubMed ID: 18469354 [TBL] [Abstract][Full Text] [Related]
29. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma. Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer. Han KY; Gu X; Wang HR; Liu D; Lv FZ; Li JN Tumour Biol; 2013 Apr; 34(2):821-5. PubMed ID: 23229099 [TBL] [Abstract][Full Text] [Related]
32. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma. Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696 [TBL] [Abstract][Full Text] [Related]
33. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry. Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531 [TBL] [Abstract][Full Text] [Related]
34. High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer. Cao X; Tang Z; Huang F; Jin Q; Zhou X; Shi J Oncotarget; 2017 Feb; 8(8):12812-12819. PubMed ID: 28086212 [TBL] [Abstract][Full Text] [Related]
35. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1. Zheng J; Xu T; Chen F; Zhang Y Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589 [TBL] [Abstract][Full Text] [Related]
36. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis. Yang M; Li Y; Tian F Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849 [TBL] [Abstract][Full Text] [Related]
37. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
38. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer. Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287 [TBL] [Abstract][Full Text] [Related]
39. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma. Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202 [TBL] [Abstract][Full Text] [Related]
40. Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival. Zhou CH; Ye LP; Ye SX; Li Y; Zhang XY; Xu XY; Gong LY J Exp Clin Cancer Res; 2012 Mar; 31(1):18. PubMed ID: 22385677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]